XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows from Operating Activities:    
Net loss $ (10,874,229) $ (6,183,345)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 225,016 290,786
Stock-based compensation 1,260,761 1,266,688
Change in fair value of warrant liabilities (835,539)  
Excess and obsolete inventory reserve adjustments 628,069 51,034
Inventory lower of cost and net realizable value adjustment 41,329 218,859
Changes in operating assets and liabilities:    
Accounts receivable (319,735) 72,269
Inventories (160,726) (603,899)
Prepaid expenses and other current assets (665,240) (65,320)
Operating lease right-of-use asset 153,138 144,311
Accounts payable 2,639,014 165,977
Accrued expenses (623,819) (80,230)
Contract liabilities 1,325 147,501
Operating lease liability (169,172) (154,901)
Net cash used in operating activities (8,699,808) (4,730,270)
Cash Flows from Investing Activities:    
Purchase of property and equipment (825,872) (185,472)
Net cash used in investing activities (825,872) (185,472)
Cash Flows from Financing Activities:    
Proceeds from issuance of Legacy Nuburu convertible promissory notes 4,100,000 100,000
Proceeds from issuance of convertible promissory notes and warrants 9,225,000  
Proceeds from the exercise of stock options 6,999 113,926
Proceeds from the issuance of Legacy Nuburu preferred stock   188,890
Proceeds from reverse recapitalization 3,243,079  
Proceeds from the issuance of preferred stock 5,000  
Proceeds from issuance of Common Stock from the Lincoln Park Purchase Agreement 2,099,997  
Payment of transaction costs related to the reverse recapitalization (4,734,913)  
Repayment of related party convertible promissory notes (675,000)  
Net cash provided by financing activities 13,270,162 402,816
NET CHANGE IN CASH DURING THE PERIOD 3,744,482 (4,512,926)
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD 2,880,254 6,007,575
CASH AND CASH EQUIVALENTS - END OF PERIOD 6,624,736 1,494,649
SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Right-of-use assets obtained in exchange for new operating lease liabilities   934,583
Deferred financing costs included in accounts payable and accrued expenses   $ 1,245,277
Transaction costs related to the reverse recapitalization not yet paid 1,007,439  
Convertible promissory notes and warrants issuance costs included in accounts payable and accrued expenses 160,345  
Issuance of common stock upon conversion of preferred stock in connection with the reverse recapitalization $ 11,575,286